Machine learning models have seeped into the fabric of our lives, from curating playlists to explaining hard concepts in a ...

Scientists at the San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), Milan, have found that gene editing using ...

ElevateBio, a newly launched pharmaceutical services firm near Boston, is not a traditional contract development and manufacturing organization (CDMO) that offers services for hire. It’s more ...

Despite these challenges, genome engineering, accomplished via cell therapy or systemic delivery of gene editing tools, holds tremendous promise for advancing the science and treatment of ...

Our research on cell-based therapies also includes cutting-edge immunotherapies that harness the patient’s own immune cells to fight disease, including genetic engineering of immune cells to attack ...

In the first part of this series, we explored how early genetic screening and gene therapy transform the lives of newborns ...

Genetic engineering of T cells can be used therapeutically ... been conceived to overcome many tumour-derived barriers to T cell therapy. For the most part, these strategies have been used in ...

Cacia: Cell and gene therapy companies rely on a number of ... Additional vector optimization steps like promoter engineering or custom capsid design that can improve the specificity of transgene ...

Dr. Jeffrey Glassberg, who has had several patients go through gene therapy trials, said the results were impressive. "These people simply don't have sickle cell anymore," said Glassberg ...

She's the first person in the United States to get treated for a genetic disorder with a revolutionary kind of genetic engineering ... what's called gene therapy to treat sickle cell disease.

Federal officials Friday approved two gene therapy treatments for sickle cell disease, welcome news for tens of thousands with the inherited blood disorder that causes terrible pain crises and ...

So, while most cell and gene therapy firms use vectors, many also examine alternative transfection approaches, continues Novak. “Despite the fact that a big proportion of cell therapies are ...